Announced Tue, 7 Jul · 18:19 IST
RTA confirmation on share demat processing for quarter ended June 2026
Compliance View source PDF
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.0%1-day move
₹1845.00
prior close
₹1843.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.1+0.1-0.5-2.0-1.9-2.9-1.8-2.9-3.3————
Up moveDown movePending
AI summary
Emcure Pharmaceuticals has filed a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate from its Registrar and Transfer Agent, MUFG Intime India, confirms that share dematerialisation requests received during the quarter were processed, securities were listed on the exchanges, and cancelled physical certificates were substituted with the depository as the registered owner within prescribed timelines. This is a standard quarterly procedural filing.
Likely market impact
Routine regulatory compliance filing. No material impact on shareholders or stock price.